Prognostic factors in carbon ion radiotherapy for pancreatic cancer

Prognostic factors in carbon ion radiotherapy for pancreatic cancer - Prognostic factors in carbon ion radiotherapy for pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056380

Enrollment

500

Registered

2024-12-06

Start date

2024-12-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases of locally advanced pancreatic cancer treated with carbon ion radiotherapy (including chemotherapy) at QST Hospital from April 2016 through March 2024. Cases of locally advanced pancreatic cancer treated with chemotherapy at chiba university hospital from April 2016 through March 2024.

Exclusion criteria

Exclusion criteria: Cytology or histology from the primary pancreatic lesion has not been performed. Has a history of radiotherapy other than those included in this study at the site to be treated. Active overlapping cancer. Has distant metastasis. The subject or his/her representative refuses to allow the use of his/her clinical data for this study.

Design outcomes

Primary

Measure	Time frame
overall survival	—

Secondary

Measure	Time frame
local control rate, progression free survival, adverse event	—

Countries

Japan

Contacts

Public ContactHiroki Kurosaki

National Institutes for Quantum and Radiological Science and Technology QST Hospital

kurosaki.hiroki@qst.go.jp043-206-3306

Outcome results